Introduction

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Volumn , Issue , 2012, Pages 1-6

  Barratt, Michael J ^a   Frail, Donald E ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

"indications discovery," new indications for existing drugs; Drug repositioning, or drug reprofiling, repurposing; Technology platforms, internal pipelines for repurposed drugs

Indexed keywords

EID: 84886540215     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118274408.ch     Document Type: Editorial

References (10)

1. DiMasi, J.A., Grabowski, H.G. (2007). The cost of biopharmaceutical R & D: Is biotech different? Managerial and Decision Economics, 28, 469-479.
2. DiMasi, J.A., Feldman, L., Seckler, A., Wilson, A. (2010). Trends and risks associated with new drug development: Success rates for investigational drugs. Clinical Pharmacology and Therapeutics, 8, 272-277.
3. Bell, A. (2005). The Viagra Story: From Laboratory to Clinical Discovery. Medicinal and Bioorganic Chemistry Foundation Winter Conference, January 24, 2005. http:// www.mbcfoundation.org/pdfs/Blockbuster%20Drug%20Symposium%20Final.pdf
4. Wang, C., Takeuchi, K., Pinto, L.H., Lamb, R.A. (1993). Ion channel activity of influenza A virus M2 protein: Characterization of the amantadine block. Journal of Virology, 67 (9), 5585-5594.
5. Verma, U., Sharma, R., Gupta, P., Kapoor, B., Bano, G., Sawhney, V. (2005). New uses for old drugs: Novel therapeutic options. Indian Journal of Pharmacology, 37 (5), 279-287.
6. Mekdeci, B. How a commonly used drug caused birth defects. http://www. birthdefects.org/research/bendectin_1.php
7. Teo, S.K., Stirling, D.I., Zeldis, J.B. (2005). Thalidomide as a novel therapeutic agent: New uses for an old product. Drug Discovery Today, 10 (2), 107-114.
8. Rare Disease Act of 2002. Public Law 107-280. November 6, 2002. 107 th U.S. Congress. http://frwebgate.access.gpo.gov/cgi - bin/getdoc.cgi?dbname=107_cong_ public_laws& docid=f:publ280.107
9. Use Information on Rare Diseases from an EU Perspective. European Commission Health & Consumer Protection Directorate General. http://ec.europa.eu/ health/ph_information/documents/ev20040705_rd05_en.pdf
10. Wikipedia. Neglected diseases. http://en.wikipedia.org/wiki/Neglected_diseases